Welcome to the latest edition of DNA Dispatch, the quarterly newsletter from OGT, your hybridisation experts.
We are proud to announce the opening of our new state-of-the-art facility. This multi-million pound investment has been fuelled by consistent company growth and growing customer demand.
Equipped with cutting-edge technology, the facilities will drive development of OGT’s trusted SureSeq™ NGS product portfolio, as well as deliver expert-led training and enhanced opportunities for collaboration.
Dr. Klaus Metzeler describes the current technology landscape and prognostic relevance of minimal residual disease (MRD) detection and demonstrates his experience using NGS-based MRD detection in acute myeloid leukaemia (AML), including OGT’s NGS-based SureSeq Myeloid MRD Panel.
Our myProbes® service has proven so popular since its inception in 2010 that we are proud to announce we have now delivered in excess of 5,000 custom FISH projects to customers all over the world.
On another note, based on feedback from customers, we are pleased to announce myProbe pack inserts have been updated to include a new chromomap, which is more user-friendly and easier to interpret. Just another improvement to the best custom FISH probe service on the market.
Our Chromosome Search Tool explores hundreds of genes included in the CytoSure® Constitutional NGS panel, their chromosomal locations, common alterations in these genes and resulting phenotypic characteristics.
In March 2023, we became the very first manufacturer of FISH probes to be granted IVDR certification.
In our latest blog we speak with Steve Chatters, Executive Vice President of Regulatory, Medical and Quality Affairs, about OGT's long-standing expertise in healthcare regulation, and the journey towards IVDR certification.
Identify and resolve common problems that occur when FISHing with our FISH 'n' Tip videos.
Today our FISH experts show you how to resolve these common problems:
Don’t forget…Our FAS team can be contacted online with free support advice